When k=10, the selected genes were EGFR, KRAS, NF1, STK11, ATM, TP53, APC, LRP1B, ERBB4, and AKT1, and the enriched pathways were non-small cell lung cancer and MAPK signaling pathway. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.